tiprankstipranks

Colin George Stott Insider Profile

4 Followers
Colin George Stott, Director at Cardiol Therapeutics, holds 142.50K shares in Cardiol Therapeutics (Ticker: CRDL).
tipranks
Colin George Stott

Colin George Stott
Cardiol Therapeutics (CRDL)
Director

Ranked #53,307 out of 98,743 Corporate Insiders

Profitable Transactions

50%
1 out of 2 Profitable Transactions

Average Return

-4.00%
Average return per transaction
Time Frame
1 Year
Compare to
No Benchmark

Insider Holdings

$315K
100.00%
A breakdown of Colin George Stott's holdings

Insider Roles

Cardiol Therapeutics
(CRDL)
Director
Roles that Colin George Stott holds in companies

Most Profitable Insider Trade

Stock:
Cardiol Therapeutics
(CRDL)
Rating:Informative Buy
Date:Jun 06, 2020 - Jun 06, 2021
Return:+46.80%
The most profitable trade made by Colin George Stott

Colin George Stott's Trading History

Company Name
Last Transaction Date
Insider Position
Last Transaction
Last Transaction Amount
Holding Value
Cardiol Therapeutics
Apr 11, 2024
Director
Uninformative Sell
$314.93K
Success Rate for
CRDL
1 out of 2 profitable transactions on
CRDL
50%
Average Return for
CRDL
Average return per transaction on
CRDL
-4.00%
Date
Transaction
Amount
No. of Shares
Price per Share
Profit
Link to Report
Jun 06, 2020
Informative Buy
C$95.60K
-
C$2.39
+46.80%
Feb 27, 2021
Informative Buy
C$99.45K
-
C$4.42
-54.80%
Feb 27, 2021
Uninformative Sell
C$65.00K
-
C$3.25
Apr 11, 2024
Uninformative Sell
C$0.00
-
C$0.00
List of latest transactions for each holding click on a transaction to see Colin George Stott's performance on stock

Colin George Stott insider profile FAQ

What is the percentage of profitable transactions made by Colin George Stott?
The percentage of profitable transactions made by Colin George Stott is 50%.
    What is the average return per transaction made by Colin George Stott?
    The average return per transaction made by Colin George Stott is -4.00%.
      What stocks does Colin George Stott hold?
      Colin George Stott holds: CRDL stocks.
        What was Colin George Stott’s latest transaction?
        Colin George Stott latest transaction was an Uninformative Sell of ―.
          What was Colin George Stott's most profitable transaction?
          Colin George Stott’s most profitable transaction was an Informative Buy of CRDL stock on June 6, 2020. The return on the trade was 46.80%.
            What is Colin George Stott's role in Cardiol Therapeutics?
            Colin George Stott's role in Cardiol Therapeutics is Director.
              How can I follow the stock ratings of top corporate insiders?
              Head over to our Expert Center to see a list of the Top 100 corporate insiders and follow the corporate insiders of your choice. Visit their profiles for more details about their stock transactions and see how they perform on a stock-by-stock basis.